ArticleJAMA network open2022

Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada.

Steven Habbous et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.